medxtmc website screenshot

medxtmc

MEDx Translational Medicine Co., Ltd (MEDx TMC) is a Suzhou, China based precision medicine company founded in 2013, formerly QIAGEN (Suzhou) Translational Medicine. It is a leading provider of companion diagnostics (CDx) and total precision-medicine solutions, offering pharma services (biomarker discovery, target validation, patient stratification, IVD/CDx R&D and commercialization), clinical testing panels for solid tumors, blood cancers and infectious diseases, and diagnostic products built on IHC, PCR and NGS platforms. MEDx has collaborated with 400+ pharmaceutical and technology partners and holds ISO 13485, ISO 17025, CAP and CNAS accreditations. It is a portfolio company of Qiming Venture Partners. MEDx TMC publishes no public developer API, developer portal, or SDKs; this profile captures company identity for the API Evangelist network.

medxtmc is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Companion Diagnostics, Molecular Diagnostics, and Biomarkers.

🌐 Visit website 📡 Source on GitHub
3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyPrecision MedicineCompanion DiagnosticsMolecular DiagnosticsBiomarkersClinical TestingHealthcareLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 3.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/medxtmc: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Medxtmc Domain Security

TLSv1.2

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 About
About

Source (apis.yml)

apis.yml Raw ↑ 
aid: medxtmc
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/medxtmc.png
name: medxtmc
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1
description: MEDx Translational Medicine Co., Ltd (MEDx TMC) is a Suzhou, China based precision medicine company founded in
  2013, formerly QIAGEN (Suzhou) Translational Medicine. It is a leading provider of companion diagnostics (CDx) and total
  precision-medicine solutions, offering pharma services (biomarker discovery, target validation, patient stratification,
  IVD/CDx R&D and commercialization), clinical testing panels for solid tumors, blood cancers and infectious diseases, and
  diagnostic products built on IHC, PCR and NGS platforms. MEDx has collaborated with 400+ pharmaceutical and technology partners
  and holds ISO 13485, ISO 17025, CAP and CNAS accreditations. It is a portfolio company of Qiming Venture Partners. MEDx
  TMC publishes no public developer API, developer portal, or SDKs; this profile captures company identity for the API Evangelist
  network.
url: https://raw.githubusercontent.com/api-evangelist/medxtmc/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Precision Medicine
- Companion Diagnostics
- Molecular Diagnostics
- Biomarkers
- Clinical Testing
- Healthcare
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/medxtmc-domain-security.yml
- type: Website
  url: https://www.medxtmc.net
- type: About
  url: https://www.medxtmc.net/Overview.shtml